Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 EUR | -0.10% | +0.51% | -44.30% |
May. 03 | AB Science: upbeat after legal success | CF |
May. 03 | French Appeals Court Acquits AB Science CEO of Insider Trading Charges | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.30% | 109M | |
+7.98% | 72.94B | |
+12.64% | 9.06B | |
-10.56% | 5.07B | |
+58.79% | 4.78B | |
+4.07% | 3.9B | |
-16.90% | 2.56B | |
+21.52% | 2.42B | |
-26.13% | 2.39B | |
+19.31% | 2.18B |
- Stock Market
- Equities
- AB Stock
- News AB Science
- AB Science Expects European Marketing Authorization for Rare Neurological Disease Drug in Early 2024